Author Correction: PI3K inhibitors are finally coming of age.

Autor:	Vanhaesebroeck B; UCL Cancer Institute, University College London, London, UK. bart.vanh@ucl.ac.uk., Perry MWD; Medicinal Chemistry, Research and Early Development, Respiratory & Immunology BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Brown JR; CLL Center, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA, USA., André F; Institut Gustave Roussy, INSERM U981, Université Paris Saclay, Paris, France., Okkenhaug K; Department of Pathology, University of Cambridge, Cambridge, UK.
Jazyk:	angličtina
Zdroj:	Nature reviews. Drug discovery [Nat Rev Drug Discov] 2021 Oct; Vol. 20 (10), pp. 798.
DOI:	10.1038/s41573-021-00300-7
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink